CTLA4 and cancer: Immunomodulatory strategies, including immune checkpoint inhibitors (anti‐PD‐1/PD‐L1), CTLA‐4 blockers, adoptive T‐cell therapy, and cancer vaccines, stimulate immune response against cancer cells.